Cardiff Oncology to Present at the Jefferies London Healthcare Conference

/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a...

Related Keywords

United Kingdom ,London ,City Of ,Joyce Allaire ,James Levine ,Cardiff Oncology Inc ,Prnewswire Cardiff Oncology Inc ,Nasdaq ,Jefferies London Healthcare Conference ,Cardiff Oncology ,Oncology Contact ,Nc ,Health Care Amp Hospitals ,Biotechnology ,Medical Pharmaceuticals ,Conference Call Announcements ,Trade Show News ,